Astera Labs (ALAB) has drawn fresh attention after reporting record Q1 2026 results, with sales nearly doubling year over year to US$308.36 million, alongside higher net income and detailed guidance for Q2.

Astera Labs’ share price has been volatile around the Q1 release, with a 1-day share price decline of 8.54%, a 30-day share price return of 64.43%, and a 1-year total shareholder return of 173.10%. This suggests momentum has been strong despite short-term swings.

If you want to see what else is moving in AI hardware and connectivity, this is a good moment to broaden your watchlist with 40 AI infrastructure stocks

With sales at US$308.36 million for Q1, guidance pointing higher for Q2, and the stock up 173.10% over 1 year, investors now face the key question: is there still a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 4.3% Undervalued

Astera Labs' most followed narrative pegs fair value at about $204.47, slightly above the last close of $195.65, which frames recent strength in a valuation context.

Expansion across multiple high-growth connectivity standards (PCIe, Ethernet, CXL, and UALink) alongside deepening partnerships with leading industry players (NVIDIA, AMD, Microsoft, SAP, Alchip) positions Astera Labs to leverage the ongoing digital transformation and migration to advanced data center architectures, reducing customer concentration risk while driving higher gross margins from increased product mix and attach rates.
Stepped increase in attach rates from broader adoption across scale-up and scale-out architectures, including non-AI use cases (for example, general purpose CPU deployments and memory expansion via Leo/CXL products), supports a diversified and resilient growth engine, further improving prospects for sustained earnings expansion and operating leverage.

Want to see what sits behind that fair value call? The narrative focuses on rapid revenue expansion, rising margins, and a rich earnings multiple that assumes serious execution.

Result: Fair Value of $204.47 (UNDERVALUED)

However, the story can change quickly if hyperscaler AI spending slows or larger chipmakers integrate similar connectivity in house, which could pressure Astera Labs’ growth assumptions.

Another Way To Look At Valuation

The narrative driven fair value suggests Astera Labs is around 4.3% undervalued at $204.47 per share, but the current P/E of 125.3x tells a different story. That is far above the US Semiconductor industry at 59.4x, the peer average at 68.4x, and even its own 80.7x fair ratio, which points to meaningful valuation risk if sentiment cools.

Next Steps

Given the mixed signals on value and sentiment so far, it makes sense to move quickly, review the data yourself, and weigh both sides of the story with 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If you stop with just one stock, you risk missing opportunities that may better match your goals, time horizon, and tolerance for bumps along the way.

• Spot potential bargains early by checking companies that currently screen as 51 high quality undervalued stocks before the wider market pays attention.
• Prioritize resilience by filtering for businesses in the solid balance sheet and fundamentals stocks screener (44 results) that may better handle tough conditions.
• Hunt for future standouts by scanning the screener containing 23 high quality undiscovered gems that most investors might not be watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.